Global Embolization Oncology Symposium and Technologies (GEST)

13th Annual Global Embolization Oncology Symposium and Technologies (GEST) Meeting is organized by Complete Conference Management (CCM) and will be held from May 09 - 12, 2019 at Sheraton New York Times Square Hotel, New York City, New York, United States of America.

Target Audience:
GEST 2019 will be of value to Interventional radiologists, oncologists, diagnostic radiologists, nurses, radiology technologists, physician assistants, and other healthcare professionals interested in the field of embolization.

CME Credit Designation Statement:
Complete Conference Management designates this live activity for a maximum of 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits:?
ANCC
For the purpose of recertification, American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

AANP
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

ARRT
Association for Vascular and Interventional Radiographers (AVIR) ARRT Accreditation. Approved by the AVIR for 25.5 Category A+ CEs

ABR
American Board of Radiology (ABR) Self – Assessments (SAMs). This program is approved for a maximum of 10.75 self-assessment credits (SAM) by Complete Conference Management. Complete Conference Management is awarded Deemed Status by the American Board of Radiology (ABR).

VIR
Association for Vascular and Interventional Radiographers (AVIR) ACE Accreditation. This program is approved by the Association for Vascular and Interventional Radiographers (AVIR) for a total of 52.75 Category A+ CE (maximum of 26)

Description:
The Global Embolization Symposium and Technologies (GEST) has an internationally recognized reputation as the leading educational resource on embolotherapy. Renowned experts from across the globe will present an intensive but practical scientific program that will focus on the latest research, advanced techniques and issues of greatest importance.

Learning Objectives:
Upon completion of this activity, the learner should be able to:
• Compare the relative advantages and timing of different endoleak therapies
• Assess current data for evaluation of upper GI bleeding treated by embolization
• Explain the role and benefit of various embolic material for GI bleeding embolization
• Determine interventional oncologic therapy decisions based on the latest evidence, established patient care standards and multidisciplinary approaches
• Describe the latest imaging techniques that may help in performing intra-arterial treatment of liver cancer.
• Compare the latest options and differences in function, characteristics and potential outcomes of various devices for embolization.
• Discuss the new therapeutic options using embolization in hemorrhoid-related bleeding,
• Analyze the potential indication of embolization in various joint disorders (frozen shoulder, knee osteoarthritis, tennis elbow, enthesopathy)
• Discuss basic and variant prostate artery anatomy and techniques to identify critical vasculature during therapy.
• Assess patient symptoms and treatment options for symptomatic benign prostatic hyperplasia, including drug treatment, surgery, and embolization.
• Assess the indication and results for PAE in BPH
• Determine the potential role of bariatric embolization
• Explain the indications and results of uterine fibroid and adenomyosis embolization.
• Summarize the advantages, limitations, technical aspects, and endpoints of various tools and approaches to visceral aneurysm treatment.
• Synthesize the results and indication for liver mets of MRCC intra-arterial treatment including Y 90, DEBIRI, Intra-arterial ports
• Determine the respective role of DEB and conventional TACE in HCC
• Identify the potential role for resorbable particles
• Restate technique, indication and results of lung and liver tumor ablation

Speakers: Kamran Ahrar, M.D. MD Anderson Cancer Center Houston, TX, Jafar Golzarian, M.D. University of Minnesota Minneapolis, Minnesota, Geert Maleux, M.D., Ph.D. University Hospitals Leuven Leuven, Belgium, Marc Sapoval, M.D., Ph.D. University Paris Descartes Hôpital Européen Georges Pompidou Paris, France, Gary Siskin, M.D. Albany Medical Center Albany, NY, James Spies, M.D. MedStar Georgetown University Hospital Washington, D.C.

Time: 8:00 am - 12:00 pm